Pharmaceutical Market Access
Published 4/2024
MP4 | Video: h264, 1920x1080 | Audio: AAC, 44.1 KHz
Language: English
| Size: 5.63 GB
| Duration: 2h 19m
Unlocking the Pathways to Innovation and Patient Care
What you'll learn
Master key market access strategies to launch successful pharmaceutical products globally
Gain expertise in health economics, pricing strategies, and regulatory frameworks, essential for pharma careers
Learn to navigate the payer ecosystem for optimal drug reimbursement and broader patient access
Understand the impact of health technology assessments (HTAs) and real-world evidence in drug approval
Acquire skills in stakeholder engagement and effective communication to influence healthcare decisions
Explore cutting-edge digital health technologies that are reshaping market access in the pharmaceutical industry
Prepare for high-demand market access roles with hands-on case studies from industry experts
Discover the role of patient advocacy in improving access to medications and shaping healthcare policies
Dive into global market access considerations, understanding diverse healthcare systems and policies
Equip yourself with the knowledge to ensure innovative drugs reach patients in need, enhancing healthcare outcomes
Requirements
No specific prerequisites are required for this transformative journey into Market Access. Whether you're new to the pharmaceutical industry or looking to expand your expertise, this course is crafted to welcome anyone with a passion for making a difference in healthcare. Embrace the opportunity to propel your career into a future where your impact is immeasurable. Let your curiosity and desire to contribute to medical innovation be your guide.
Description
Embark on an enlightening adventure into the pivotal world of Pharmaceutical Market Access, a crucial domain pivotal to the advancement of healthcare and patient well-being. This detailed and expansive course delves deep into the core aspects of Health Technology Assessment (HTA), Real World Evidence (RWE), Health Economics and Outcomes Research (HEOR), Patient Access, Innovation, and Early Access, uncovering the layers and complexities involved in bringing revolutionary medical treatments from conception to the hands of those in need.With a curriculum designed for both seasoned professionals and newcomers eager to leave their mark in the pharmaceutical sector, this course offers a rare glimpse into the strategic and operational facets of market access. You will be equipped with the knowledge to not only understand but also influence the multifaceted decision-making processes that determine the success and reach of new healthcare solutions.Through a blend of theoretical knowledge and practical insights, gain the expertise to navigate the regulatory landscapes, understand the economic impact, and advocate for patient access to essential medications. Learn from industry experts and case studies that bring to life the challenges and triumphs of ensuring that groundbreaking therapies are available, affordable, and attainable for patients around the globe.This course is your gateway to becoming a key player in the pharmaceutical industry, where you'll be empowered to drive innovation, influence healthcare policy, and contribute to the shaping of future medical breakthroughs. By enrolling, you're not just signing up for a course; you're stepping into a community dedicated to making a lasting impact on global health. Your journey towards mastering Pharmaceutical Market Access starts here. Seize this opportunity to be at the forefront of healthcare evolution, and play a part in delivering hope and healing to millions worldwide.
Overview
Section 1: Introduction to Market Access
Lecture 1 Introduction
Section 2: Health Technology Assessment (HTA)
Lecture 2 Learning materials
Lecture 3 HTA introduction
Lecture 4 Decoding HTA: The key to pharmaceutical market access
Lecture 5 Decoding global HTA practices
Lecture 6 Stakeholder engagement: The heart of HTA
Lecture 7 Mastering HTA: A strategy for market access
Section 3: HEOR (Health Economic & Outcome Research)
Lecture 8 Learning materials
Lecture 9 HEOR: The backbone of healthcare decision making
Lecture 10 Decoding health economics
Lecture 11 Fundamentals of outcomes research
Lecture 12 Decoding data sources & methodologies in HEOR
Lecture 13 Unraveling the power of HEOR modelling
Lecture 14 Decoding PROs: The patient´s voice
Lecture 15 HEOR: The game changer in drug development
Lecture 16 Decoding HEOR: A regulatory and payer perspective
Section 4: Real World Evidence
Lecture 17 Learning materials
Lecture 18 RWE: A transformative approach in healthcare
Lecture 19 Unveiling the sources of RWE
Lecture 20 Regulatory framework for RWE
Lecture 21 RWE in drug development and market access
Lecture 22 Decoding RWE: Methodologies and techniques
Lecture 23 Navigating the Challenges of RWE
Section 5: Patient Access
Lecture 24 Learning materials
Lecture 25 Unlocking patient access
Lecture 26 Unveiling the barriers to patient access
Lecture 27 The power of patient advocacy
Lecture 28 Patient access schemes
Lecture 29 Decoding regulatory fremaworks for patient access
Lecture 30 Stakeholder engagement for improved patient access
Section 6: Early Access
Lecture 31 Learning materials
Lecture 32 Unlocking early access mechanisms
Lecture 33 Early access in UK
Lecture 34 Early access in Italy
Section 7: Innovation
Lecture 35 Learning materials
Lecture 36 Innovation in HTA
Lecture 37 Unleashing healthcare innovation: The european approach
Lecture 38 Mastering innovation in HTA
Lecture 39 Innovation. schemes in UK healthcare
Lecture 40 Italy: Example of innovation
Lecture 41 Innovation in French healthcare
Section 8: Regulatory
Lecture 42 Learning materials
Lecture 43 Navigating the regulatory affairs in market access
Lecture 44 Decoding the FDA´s drug approval pathway
Lecture 45 EMA (European Medicine Agency)
Section 9: EUnetHTA
Lecture 46 Learning materials
Lecture 47 Common joint assessments
Lecture 48 EUnetHTA: Shaping market access in Europe
This course opens doors to one of the most rewarding and high-demand careers in the pharmaceutical industry: Market Access. If you're intrigued by the crucial role of bringing medical innovations to the patients who need them, this course is designed for you. Tailored for both newcomers eager to learn how drugs are brought to market and professionals aiming to advance their careers within pharmaceutical companies, life sciences consulting, or HEOR (Health Economics and Outcomes Research) analysis. Take the first step towards a career where your work is not only well-compensated but also makes a meaningful difference in people's lives. Join us and become an expert in Market Access, a field with boundless growth and opportunities!
Free search engine download: Pharmaceutical Market Access
